Structure‐Based Discovery of N‐Aryl‐N′‐Heteroaryl Ureas as Disruptors of the Oncogenic MTDH–SND1 Protein–Protein Interaction: In Silico Insights and Biochemical Validation
Archiv der Pharmazie · 2026-06 · 359 (6)
DOI: 10.1002/ardp.70284 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archiv der Pharmazie, online erschienen am 03.07.2026. Verfasst von Emadeldin M Kamel und 6 weiteren Autor:innen. Beteiligte Einrichtung: Chemistry Department, Faculty of Science, Beni-Suef University, Beni-Suef, Egypt. Hauptthemen laut MEDLINE: Urea, Drug Discovery. Die Arbeit nennt 28 Literaturangaben. Gefördert von: Ministerio de Ciencia, Innovación y Universidades, Princess Nourah bint Abdulrahman University.
Abstract (Originalsprache)
The metadherin (MTDH)–staphylococcal nuclease domain‐containing protein 1 (SND1) interaction is a functionally important protein–protein interaction implicated in tumor progression, making it an attractive but challenging therapeutic target. In this study, we employed an integrated in silico‐to‐in vitro virtual screening workflow to identify small‐molecule disruptors of the MTDH–SND1 interface from a focused library of 1487 N‐aryl–N′‐heteroaryl ureas. After sequential filtering, four compounds (C1–C4) were prioritized for long‐timescale evaluation. Docking showed that all four hits occupied the targeted SND1 interfacial hot‐spot pocket with binding modes consistent with disruption of MTDH recognition. The 1000 ns MD simulations, together with MM/PBSA, protein–protein disruption metrics, and free energy landscape analyses, revealed ligand‐dependent destabilization of the complex, with C3 producing the strongest weakening of the MTDH–SND1 interface and the broadest conformational redistribution, while C4 showed a somewhat weaker but still favorable profile. ADMET prediction indicated that all compounds satisfied basic drug‐likeness criteria, although C3 displayed greater developability liabilities, whereas C4 showed the most balanced predicted pharmacokinetic and toxicity profile. Experimental validation using split‐luciferase complementation assays confirmed concentration‐dependent inhibition of the MTDH–SND1 interaction by all four compounds in both cell‐free and cell‐based formats, with C3 showing the greatest potency (cell‐free IC 50 = 2.81 ± 0.31 μM; cell‐based IC 50 = 11.30 ± 1.80 μM), followed by C4, C1, and C2, and with minimal activity in the linked‐luciferase counter‐screen. Collectively, these findings identify N‐aryl–N′‐heteroaryl ureas as a promising scaffold for MTDH–SND1 PPI disruption, establish C3 as the leading hit, and support C4 as a valuable secondary scaffold for future optimization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Chemistry Department, Faculty of Science, Beni-Suef University, Beni-Suef, Egypt.
- Department of Biology, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia.
- Department of Biology, College of Science, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
- Department of Public Health, College of Applied Medical Sciences, Qassim University, Buraydah, Saudi Arabia.
- Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah, Saudi Arabia.
- Departamento de Química and Institute for Advanced Research in Chemical Science (IAdChem), Facultad de Ciencias, Módulo 13, Universidad Autónoma de Madrid, Madrid, Spain.
ORCID-Profile: Emadeldin M Kamel
Förderung
- Ministerio de Ciencia, Innovación y Universidades
- Princess Nourah bint Abdulrahman University
Zitieren
APA
Kamel, E. M., Khadrawy, S. M., Allam, A. A., Othman, S. I., Abalkhail, A., Aba Alkhayl, F. F., & Lamsabhi, A. M. (2026). Structure‐Based Discovery of N‐Aryl‐N′‐Heteroaryl Ureas as Disruptors of the Oncogenic MTDH–SND1 Protein–Protein Interaction: In Silico Insights and Biochemical Validation. Archiv der Pharmazie, 359(6). https://doi.org/10.1002/ardp.70284
Vancouver
Kamel EM, Khadrawy SM, Allam AA, Othman SI, Abalkhail A, Aba Alkhayl FF, et al. Structure‐Based Discovery of N‐Aryl‐N′‐Heteroaryl Ureas as Disruptors of the Oncogenic MTDH–SND1 Protein–Protein Interaction: In Silico Insights and Biochemical Validation. Archiv der Pharmazie. 2026;359(6). doi:10.1002/ardp.70284
BibTeX
@article{Kamel2026,
author = {Kamel, Emadeldin M and Khadrawy, Sally Mostafa and Allam, Ahmed A and Othman, Sarah I and Abalkhail, Adil and Aba Alkhayl, Faris F and Lamsabhi, Al Mokhtar},
title = {Structure‐Based Discovery of N‐Aryl‐N′‐Heteroaryl Ureas as Disruptors of the Oncogenic MTDH–SND1 Protein–Protein Interaction: In Silico Insights and Biochemical Validation},
journal = {Archiv der Pharmazie},
year = {2026},
volume = {359},
number = {6},
doi = {10.1002/ardp.70284}
}
EUVIMED